Beilstein J. Org. Chem. 2013, 9, 303–312.
the corresponding crystals. The new complexes were character- 13C NMR (CDCl3, δ) 31.2, 31.3 (NCH2C6H3(C(CH3)3-3,5),
ized by 1H NMR, 13C NMR, IR and elemental analysis tech- 31.4, 31.7, 34.7, 34.8 (NCH2C6H2(OCH3)3-3,4,5), 41.0, 41.1
niques, which support the proposed structures.
(NCH2C6H3(C(CH3)3-3,5), 53.2, 53.9 (NCH2C6H3(C(CH3)3-3,
5), 56.3, 56.4 (NCH2C6H2(OCH3)3-3,4,5), 104.4, 104.8, 111.8,
As described in [49], the air and moisture-stable palladium- 112.4, 121.1, 121.3, 123.4, 129.9, 130.4, 133.1, 133.5, 133.9,
carbene complexes (1–9) were soluble in halogenated solvents 134.3, 134.4, 134.7, 137.7, 151.2, 151.5, 153.5, 153.7
and insoluble in nonpolar solvents. Palladium complexes ex- (NC6H4N, NCH2C6H3(C(CH3)3-3,5 and NCH2C6H2(OCH3)3-
hibit a characteristic ν(NCN) band typically at 1407–1477 cm−1. 3,4,5), 181.2 and 182.3 (Pd-Ccarbene); IR (cm−1) ν(CN): 1447;
The formation of the Pd–NHC complexes was confirmed by the Anal. calcd for C64H80N4O6PdBr2: C, 60.64; H, 6.36; N, 4.42;
absence of the 1H NMR resonance signal of the acidic benzimi- found: C, 60.57; H, 6.54; N, 4.45.
dazolium C2–H. The 13C NMR spectra of Pd–NHC complexes
exhibit a resonance signal in the 181.2–183.6 ppm range Dibromo-bis[1,3-bis(3,5-di-tert-butylbenzyl)benzimidazol-2-
ascribed to the carbenic carbon atom, which is consistent with ylidene]palladium(II) (3): Yield: 0.27 g, 82%; mp
the reported values for Pd–NHC complexes [43]. NMR data 248–250 °C; 1H NMR (CDCl3, δ) 1.18 (s, 72H,
showed that complexes 2 and 4–7 were cis/trans mixtures.
NCH2C6H3(C(CH3)3)-3,5), 5.80 (s, 8H, NCH2C6H3(C(CH3)3-
3,5), 6.14–7.48 (m, 20H, NC6H4N and NCH2C6H3(C(CH3)3-
3,5); 13C NMR (CDCl3, δ) 31.4 (NCH2C6H3(C(CH3)3)-3,5),
41.02 (NCH2C6H3(C(CH3)3)-3,5), 53.9 (NCH2C6H3(C(CH3)3-
General procedure for the preparation of the
palladium–NHC complexes
As described in [50], to a solution of benzimidazolium salts 3,5), 111.6, 112.2, 121.3, 121.5, 122.3, 122.8, 133.4, 134.4,
(10 mmol) in DMSO (5 mL) was added palladium(II) diacetate 134.6, 151.1, 151.2 (NC6H4N and NCH2C6H3(C(CH3)3-3,5)),
(5 mmol) under argon, and the resulting mixture was stirred at 182.5 (Pd-Ccarbene); IR (cm−1) ν(CN): 1477; Anal. calcd for
room temperature for 2 h, then at 60 °C for 4 h, at 80 °C for 2 h C74H100N4PdBr2: C, 67.75; H, 7.68; N, 4.27; found: C, 67.72;
and finally at 110 °C for 2 h. Volatiles were removed in vacuo, H, 7.64; N, 4.27.
and the residue was washed twice with THF (5 mL). The com-
plex was crystallized from dichloromethane/diethyl ether 1:3 at cis/trans-Dichloro-bis[1-(3,5-di-tert-butylbenzyl)-3-(2,3,4,5,6-
room temperature.
pentamethylbenzyl)benzimidazol-2-ylidene]palladium(II)
(4): Yield: 0.27 g, 82%; mp 310–312 °C; 1H NMR (CDCl3, δ)
Dibromo-bis[1-(3,5-di-tert-butylbenzyl)-3-(2-methoxy- 1.27, 1.29 (s, 36 H, NCH2C6H3(C(CH3)3-3,5)), 2.20, 2.23, 2.24,
ethyl)benzimidazol-2-ylidene]palladium(II) (1): Yield: 0.29 2.29, 2.30, 2.34 (s, 30H, NCH2C6(CH3)5-2,3,4,5,6), 5.30 and
g, 87%; mp 172–174 °C; 1H NMR (CDCl3, δ) 1.29 (t, J = 7.0 5.40 (s, 4H, NCH2C6(CH3)5-2,3,4,5,6), 5.53, 5.54 (s, 4H,
Hz, 4H, NCH2CH2OCH3), 1.31 (t, J = 7.0 Hz, 4H, NCH2CH2- NCH2C6H3(C(CH3)3-3,5)), 6.04–7.55 (m, 14H, NC6H4N and
OCH3), 1.33 (s, 36H, NCH2C6H3(C(CH3)3)-3,5), 2.63 (s, 6H, NCH2C6H3(C(CH3)3-3,5)); 13C NMR (CDCl3, δ) 31.3, 31.4
NCH2CH2OCH3), 5.10 (s, 4H, NCH2C6H3(C(CH3)3-3,5)), (NCH2C6H3(C(CH3)3-3,5), 41.0, 41.1 (NCH2C6H3(C(CH3)3-
6.89–7.6 (m, 14H, NC6H4N and NCH2C6H3(C(CH3)3-3,5)); 3,5)), 17.1, 17.2, 17.3, 17.6, 17.7, 17.8 (NCH2C6(CH3)5-
13C NMR (CDCl3, δ) 31.5 (NCH2C6H3(C(CH3)3)-3,5), 34.8 2,3,4,5,6), 51.2, 51.3 (NCH2C6(CH3)5-2,3,4,5,6), 51.5, 51.6
(NCH2C6H3(C(CH3)3-3,5)), 35.0 (NCH2CH2OCH3), 41.0 (NCH2C6H3(C(CH3)3-3,5)), 111.2, 111.4, 111.8, 121.3, 121.5,
(NCH2C6H3(C(CH3)3)-3,5)), 48.3 (NCH2CH2OCH3), 58.8 122.0, 122.5, 122.7, 122.8, 128.5, 128.6, 132.9, 133.0, 134.3,
(NCH2C6H3(C(CH3)3-3,5)), 111.1, 111.2, 121.7, 122.3, 122.7, 134.4, 134.5, 134.6, 134.8, 134.9, 135.1, 151.0, 151.1 (NC6H4N
122.9, 134.2, 134.6, 151.1, 151.3 (NC6H4N and NCH2C6H3- and NCH2C6H3(C(CH3)3-3,5)), 182.4, 182.5 (Pd-Ccarbene); IR
(C(CH3)3-3,5)), 183.6 (Pd-Ccarbene); IR (cm−1) ν(CN): 1407; (cm−1) ν(CN): 1451; Anal. calcd for C68H84N4PdCl2: C, 71.97;
Anal. calcd for C50H68N4PdBr2: C, 60.58; H, 6.91; N, 5.65; H, 7.46; N, 4.94; found: C, 71.92; H, 7.64; N, 4.97.
found: C, 60.47; H, 6.94; N, 5.63.
cis/trans-Dibromo-bis[1-(2,4,6-trimethylbenzyl)-3-(2-(2-eth-
cis/trans-Dibromo-bis[1-(3,5-di-tert-butylbenzyl)-3-(3,4,5- oxy)phenoxyethyl)benzimidazol-2-ylidene]palladium(II) (5):
trimethoxybenzyl)benzimidazol-2-ylidene]palladium(II) (2): Yield: 0.33 g; 81%; mp 238–240 °C; 1H NMR (CDCl3, δ) 1.23,
Yield: 0.29 g, 87%; mp 160–162 °C; 1H NMR (CDCl3, δ) 1.16, 1.39 (t, J = 7.0 Hz, 6H, NCH2CH2OC6H4(OCH2CH3)-2), 2.29,
1.21 (s, 36H, NCH2C6H3(C(CH3)3-3,5), 3.66, 3.80, 3.81, 3.86 2.34, 2.35, 2.36 (s, 18H, NCH2C6H2(CH3)-2,4,6), 3.89, 4.01 (q,
(s, 18 H, NCH2C6H2(OCH3)3-3,4,5), 5.32, 5.37 (s, 4H, J = 7.0 Hz, 4H, NCH2CH2OC6H4(OCH2CH3)-2), 4.81, 4.83 (t,
N C H 2 C 6 H 3 ( C ( C H 3 ) 3 - 3 , 5 ) , 5 . 7 4 , 5 . 7 9 ( s , 4 H , J = 5.9 Hz, 4H, NCH2CH2OC6H4(OCH2CH3)-2), 5.39, 5.41 (t,
NCH2C6H2(OCH3)3-3,4,5), 6.09–7.39 (m, 18H, NC6H4N, J = 5.9, 4H, NCH2CH2OC6H4(OCH2CH3)-2), 6.03, 6.13 (s, 4H,
NCH2C6H3(C(CH3)3-3,5 and NCH2C6H2(OCH3)3-3,4,5); NCH2C6H2(CH3)-2,4,6), 6.80–7.77 (m, 20H, NC6H4N,
309